by Steven Ertelt
February 1, 2006
Washington, DC (LifeNews.com) — Pro-life advocates are supporting an effort by lawmakers in Congress to approve legislation that would require the FDA to suspend sales of the dangerous RU 486 abortion drug while it conducts a probe into its safety. The drug has been responsible for the deaths of five women in the U.S. and has injured more than 800 more.
Deirdre McQuade, of the pro-life office of the U.S. Conference of Catholic Bishops, and other pro-life leaders attended the press conference pro-life lawmakers organized Wednesday.
"How many more women must die before we take a close second look at RU-486," she asked.
"After five years of trauma and death associated with RU-486, the FDA’s response has been limited to one health advisory and amended drug labeling," she complained.
"The FDA should never have approved the drug – which is 10 times more dangerous than surgical abortion – in the first place, Concerned Women for American president Wendy Wright added.
"But now it is the duty of Congress to take a stand for women’s health and pass this law as soon as possible," Wright said.
Dr. Randy O’Bannon, director of research at National Right to Life, agreed and said he worries the tally of abortion deaths and complications has been underreported.
"The system waits for prescribers to call and report adverse events to the distributor, but [an abortion center] may never see or hear from a woman again once she leaves their door," he explained.
"How many women never tell their families they’ve taken the abortion pill? How many are not even able to tell the doctor in the ER," he wondered.
Other groups have also endorsed the legislation, HR 1079, sponsored by pro-life Rep Roscoe Bartlett, a Maryland Republican. Those groups include Democrats for Life, the Silent No More Awareness Campaign, Christian Coalition, the Susan B. Anthony List, and others.